Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Fidia Spa ( (IT:FDA) ) is now available.
Fidia S.p.A. has been mandated by CONSOB to provide monthly financial updates, including details on its net financial position, overdue debts, and changes in relationships with related parties. The company is currently executing a convertible bond loan agreement with Global Growth Holding Limited, which is part of its strategy to strengthen its financial position. This ongoing financial operation is crucial for maintaining business continuity and supporting its industrial and financial plans.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.50 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A. operates in the financial sector and is listed on the Euronext Milan market. The company is involved in financial operations, including convertible bond loans, and adheres to international accounting standards.
YTD Price Performance: -93.64%
Average Trading Volume: 446,605
Technical Sentiment Signal: Strong Sell
Current Market Cap: €2.2M
Learn more about FDA stock on TipRanks’ Stock Analysis page.